News and Trends 5 Apr 2023 Mosaic Therapeutics closes $28M series A funding …spin-out company from the Wellcome Sanger Institute, with notable achievements including being the single largest contributor to the Human Genome Project, co-founding the International Cancer Genome Consortium, and identifying specific… April 5, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 2 Jul 2024 Swiss biotech going strong in 2024: 18 companies to put on your radar …round fortified by an investment from Bristol Myer Squibb in 2024. Haya Therapeutics Haya Therapeutics focuses on blocking long non-coding RNAs found in the human genome, which play a role… July 2, 2024 - 20 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 27 Dec 2017 The Biggest Biotech News of 2017: What Happened This Year? …this authorization to kick off clinical testing and then a €19M Series B. Its CEO Christine Placet is also on our list of Top Women Entrepreneurs. https://www.labiotech.eu/pathology-atlas-cancer-genome/ Sweden launched an… December 27, 2017 - 3 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 28 Nov 2022 Replay receives $1.5M grant for hypoimmunogenic technology platform Genome writing company Replay has received a $1.56 million grant from the Bill & Melinda Gates Foundation to accelerate the development of uCell, a proprietary hypoimmunogenic technology platform. Replay’s uCell… November 28, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 18 Oct 2022 Empyrean Neuroscience launches with $22M to target CNS disorders …“Oz” Azam, chief executive officer, and Fred Grossman, chief medical officer, lead the company. Through precision targeting and engineering of the fungal and plant genomes, Empyrean is working to enhance… October 18, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 3 Dec 2018 First-in-Class Cancer Drug Gets €50M Boost …Aprea’s lead candidate drug activates a protein called p53, which suppresses tumor cell proliferation. Known as the ‘guardian of the genome’, mutations of p53 are more common in cancer than… December 3, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 12 Feb 2024 RNA editing set to take off: could DNA’s short-lived cousin overcome the limitations of CRISPR gene editing? …this is that, unlike DNA editing systems, GalNAc-conjugated oligonucleotides can target the RNA to be taken up by cells. However, according to Gregory Davis, a genome engineer at Sangamo Therapeutics,… February 12, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 28 Nov 2017 Cheap DNA Tests for Everyone! Italian Biotech Launches €149 Kit …risk of heart attacks, muscle fatigue, digestion, blood and the side effects of different drugs. The kit tests more than 650,000 SNPs, which comprehensively tests the genome for mutations that… November 28, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 22 Jan 2019 No Guts, No Glory: How Microbiome Research is Changing Medicine …on our skin, inside our gut, and pretty much everywhere in the human body. Their genes outnumber ours by 150 times. Some scientists refer to them as our ‘second genome,’… January 22, 2019 - 10 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 24 Mar 2023 Metabolism of RNA linked to leukemia …patients to ensure genome integrity via splicing regulation. Blocking this mechanism drastically accelerates progression to aggressive leukemia,” said Ciesla, a postdoctoral fellow in the RNA and Stem Cell Biology group… March 24, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 29 Apr 2019 Viruses Evolve to Defeat CRISPR-Cas9 in Genetically-Modified Plants …is unrelated to using CRISPR-Cas9 as a genome-editing tool. A team of scientists in Switzerland, Canada, and Belgium used bacteria to deliver the CRISPR-Cas9 genes to cassava plants. The team… April 29, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 10 Feb 2020 Meiogenix, Bayer Team Up to Boost Genetic Diversity in Crop Breeding Bayer and the French biotech company Meiogenix will work together to advance the development of Meiogenix’s plant breeding and genome editing technologies with the hope of improving food crops for… February 10, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email